UniProt ID | EAF6_HUMAN | |
---|---|---|
UniProt AC | Q9HAF1 | |
Protein Name | Chromatin modification-related protein MEAF6 | |
Gene Name | MEAF6 {ECO:0000312|HGNC:HGNC:25674} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 191 | |
Subcellular Localization | Nucleus, nucleolus . Chromosome, centromere, kinetochore . | |
Protein Description | Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histone H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. Component of the HBO1 complex which has a histone H4-specific acetyltransferase activity, a reduced activity toward histone H3 and is responsible for the bulk of histone H4 acetylation in vivo. Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity.. | |
Protein Sequence | MAMHNKAAPPQIPDTRRELAELVKRKQELAETLANLERQIYAFEGSYLEDTQMYGNIIRGWDRYLTNQKNSNSKNDRRNRKFKEAERLFSKSSVTSAAAVSALAGVQDQLIEKREPGSGTESDTSPDFHNQENEPSQEDPEDLDGSVQGVKPQKAASSTSSGSHHSSHKKRKNKNRHRIDLKLNKKPRADY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAMHNKAAP ------CCCCCCCCC | 14.13 | - | |
6 | Ubiquitination | --MAMHNKAAPPQIP --CCCCCCCCCCCCC | 31.11 | - | |
24 (in isoform 3) | Ubiquitination | - | 67.51 | - | |
24 | Ubiquitination | RELAELVKRKQELAE HHHHHHHHHHHHHHH | 67.51 | 32015554 | |
26 | Ubiquitination | LAELVKRKQELAETL HHHHHHHHHHHHHHH | 42.27 | 29967540 | |
26 (in isoform 3) | Ubiquitination | - | 42.27 | - | |
66 | Phosphorylation | RGWDRYLTNQKNSNS HHHHHHHHCCCCCCC | 27.03 | 27174698 | |
69 | Sumoylation | DRYLTNQKNSNSKND HHHHHCCCCCCCHHH | 65.50 | 28112733 | |
69 | Acetylation | DRYLTNQKNSNSKND HHHHHCCCCCCCHHH | 65.50 | 19608861 | |
69 | Ubiquitination | DRYLTNQKNSNSKND HHHHHCCCCCCCHHH | 65.50 | 27667366 | |
69 (in isoform 3) | Acetylation | - | 65.50 | - | |
71 | Phosphorylation | YLTNQKNSNSKNDRR HHHCCCCCCCHHHHH | 49.90 | 20068231 | |
71 (in isoform 3) | Phosphorylation | - | 49.90 | - | |
73 | Phosphorylation | TNQKNSNSKNDRRNR HCCCCCCCHHHHHHH | 32.43 | 27174698 | |
74 | Acetylation | NQKNSNSKNDRRNRK CCCCCCCHHHHHHHH | 68.09 | 19608861 | |
74 (in isoform 3) | Acetylation | - | 68.09 | - | |
74 | Ubiquitination | NQKNSNSKNDRRNRK CCCCCCCHHHHHHHH | 68.09 | 24816145 | |
81 | Acetylation | KNDRRNRKFKEAERL HHHHHHHHHHHHHHH | 65.42 | 26051181 | |
83 | Acetylation | DRRNRKFKEAERLFS HHHHHHHHHHHHHHC | 60.08 | 26051181 | |
90 | Phosphorylation | KEAERLFSKSSVTSA HHHHHHHCCCHHHHH | 35.90 | 24719451 | |
91 | Ubiquitination | EAERLFSKSSVTSAA HHHHHHCCCHHHHHH | 39.14 | 32015554 | |
91 (in isoform 3) | Acetylation | - | 39.14 | - | |
91 | Acetylation | EAERLFSKSSVTSAA HHHHHHCCCHHHHHH | 39.14 | 19608861 | |
101 | Phosphorylation | VTSAAAVSALAGVQD HHHHHHHHHHHCCHH | 16.91 | - | |
113 | Ubiquitination | VQDQLIEKREPGSGT CHHHHHHHCCCCCCC | 55.88 | 32015554 | |
113 (in isoform 3) | Ubiquitination | - | 55.88 | - | |
113 | Sumoylation | VQDQLIEKREPGSGT CHHHHHHHCCCCCCC | 55.88 | - | |
113 | Sumoylation | VQDQLIEKREPGSGT CHHHHHHHCCCCCCC | 55.88 | 25114211 | |
118 | Phosphorylation | IEKREPGSGTESDTS HHHCCCCCCCCCCCC | 53.94 | 26503892 | |
118 (in isoform 3) | Phosphorylation | - | 53.94 | 21406692 | |
120 | Phosphorylation | KREPGSGTESDTSPD HCCCCCCCCCCCCCC | 33.73 | 26503892 | |
120 (in isoform 3) | Phosphorylation | - | 33.73 | 21406692 | |
122 (in isoform 3) | Phosphorylation | - | 46.13 | 21406692 | |
122 | Phosphorylation | EPGSGTESDTSPDFH CCCCCCCCCCCCCCC | 46.13 | 30278072 | |
124 | Phosphorylation | GSGTESDTSPDFHNQ CCCCCCCCCCCCCCC | 51.98 | 30278072 | |
124 (in isoform 3) | Phosphorylation | - | 51.98 | 21406692 | |
125 | Phosphorylation | SGTESDTSPDFHNQE CCCCCCCCCCCCCCC | 27.71 | 30278072 | |
125 (in isoform 3) | Phosphorylation | - | 27.71 | 21406692 | |
136 | Phosphorylation | HNQENEPSQEDPEDL CCCCCCCCCCCHHHC | 39.77 | 17525332 | |
136 (in isoform 3) | Phosphorylation | - | 39.77 | 21406692 | |
146 | Phosphorylation | DPEDLDGSVQGVKPQ CHHHCCCCCCCCCCC | 15.78 | 23927012 | |
146 (in isoform 3) | Phosphorylation | - | 15.78 | 21406692 | |
151 | Acetylation | DGSVQGVKPQKAASS CCCCCCCCCCCCCCC | 48.86 | 23236377 | |
160 | Phosphorylation | QKAASSTSSGSHHSS CCCCCCCCCCCCCCH | 34.35 | - | |
167 | Phosphorylation | SSGSHHSSHKKRKNK CCCCCCCHHCCCCCC | 34.66 | - | |
169 | Acetylation | GSHHSSHKKRKNKNR CCCCCHHCCCCCCCC | 57.11 | 30583989 | |
178 (in isoform 2) | Phosphorylation | - | 22.37 | 27732954 | |
178 (in isoform 3) | Phosphorylation | - | 22.37 | 24117733 | |
180 (in isoform 2) | Phosphorylation | - | 37.39 | 27732954 | |
180 (in isoform 3) | Phosphorylation | - | 37.39 | 24117733 | |
182 | Acetylation | NRHRIDLKLNKKPRA CCCCCCCCCCCCCCC | 46.39 | 25953088 | |
185 (in isoform 2) | Phosphorylation | - | 74.68 | 27732954 | |
185 | Ubiquitination | RIDLKLNKKPRADY- CCCCCCCCCCCCCC- | 74.68 | 24816145 | |
195 | Ubiquitination | RADY----------- CCCC----------- | 24816145 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EAF6_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EAF6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EAF6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-69; LYS-74 AND LYS-91, ANDMASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118; THR-120 ANDSER-122, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136, AND MASSSPECTROMETRY. |